Publication: Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
cris.customurl | 16622 | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.departmentbrowse | Klinische Psychologie und Psychotherapie | |
cris.virtual.departmentbrowse | Klinische Psychologie und Psychotherapie | |
cris.virtual.departmentbrowse | Klinische Psychologie und Psychotherapie | |
cris.virtual.departmentbrowse | Klinische Psychologie und Psychotherapie | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | 8838d34d-9abf-4522-ab9c-24fea6d26097 | |
cris.virtualsource.department | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
dc.contributor.author | Konigorski, Stefan | |
dc.contributor.author | Meißner, Carina | |
dc.contributor.author | Fadai, Tahmine | |
dc.contributor.author | Warren, Claire V. | |
dc.contributor.author | Falkenberg, Irina | |
dc.contributor.author | Kircher, Tilo | |
dc.contributor.author | Nestoriuc, Yvonne | |
dc.date.issued | 2023-10 | |
dc.description.abstract | Background Antidepressant discontinuation is associated with a broad range of adverse effects. Debilitating discontinuation symptoms can impede the discontinuation process and contribute to unnecessary long-term use of antidepressants. Antidepressant trials reveal large placebo effects, indicating a potential use of open-label placebo (OLP) treatment to facilitate the discontinuation process. We aim to determine the effect of OLP treatment in reducing antidepressant discontinuation symptoms using a series of N-of-1 trials. Methods A series of randomized, single-blinded N-of-1 trials will be conducted in 20 patients with fully remitted DSM-V major depressive disorder, experiencing moderate to severe discontinuation symptoms following antidepressant discontinuation. Each N-of-1 trial consists of two cycles, each comprising two-week alternating periods of OLP treatment and of no treatment in a random order, for a total of eight weeks. Our primary outcome will be self-reported discontinuation symptoms rated twice daily via the smartphone application ‘StudyU’. Secondary outcomes include expectations about discontinuation symptoms and (depressed) mood. Statistical analyses will be based on a Bayesian multi-level random effects model, reporting posterior estimates of the overall and individual treatment effects. Discussion Results of this trial will provide insight into the clinical application of OLP in treating antidepressant discontinuation symptoms, potentially offering a new cost-effective therapeutic tool. This trial will also determine the feasibility and applicability of a series of N-of-1 trials in a clinical discontinuation trial. Trial registration ClinicalTrials.gov: NCT05051995, first registered September 20, 2021. | |
dc.description.version | VoR | |
dc.identifier.articlenumber | 749 (2023) | |
dc.identifier.doi | 10.1186/s12888-023-05184-y | |
dc.identifier.issn | 1471-244X | |
dc.identifier.uri | https://openhsu.ub.hsu-hh.de/handle/10.24405/16622 | |
dc.language.iso | en | |
dc.relation.ispartof | BMC Psychiatry | |
dc.relation.journal | BMC Psychiatry | |
dc.relation.orgunit | Klinische Psychologie und Psychotherapie | |
dc.rights.accessRights | metadata only access | |
dc.title | Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study] | |
dc.type | Forschungsartikel | |
dspace.entity.type | Publication | |
hsu.peerReviewed | ✅ | |
hsu.uniBibliography | ✅ | |
oaire.citation.volume | 23 |